- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01871584
A Post Marketing Study of Angel of Water™ for Colon Cleansing as Preparation for Colonoscopy
June 4, 2013 updated by: novoGI
A Prospective, Single Center, Single-blinded, Randomized Study, of the Angel of Water™ for Colon Cleansing as Preparation for Colonoscopy
The aim of this study is to demonstrate the efficacy of the hydrocolonic lavage method in order to prepare the colon prior to performing a colonoscopy, by comparison the hydrotherapy to standard preparation solution.
Hypothesis: Colon cleansing by hydrotherapy is as good as colon cleansing by standard preparation solution.
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Detailed Description
Colonoscopy is the current standard method for evaluation of the colon.
It has an indispensable place in the diagnosis and treatment of colon diseases.
Diagnostic accuracy and therapeutic safety of colonoscopy depends on the quality of the colonic cleansing or preparation.
Good preparation of the bowel is necessary prior to colonoscopy, to allow clear visualization of the bowel wall and any pathology within.
The proposed study is a post-marketing study in which the study device, the Angel of Water system will be used for hydrotherapy of the colon in adult subjects scheduled for elective colonoscopy, instead of standard preparation solution.
The effectiveness of the hydrotherapy in comparison to the standard preparation will be defined by evaluating colon cleanliness, subject's attitude and the duration of colonoscopy procedure.
Study Type
Interventional
Enrollment (Anticipated)
160
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Strasbourg, France
- Recruiting
- Department of Hepato-Gastroenterology, Nouvel Hopital Civil
-
Contact:
- Gerard Gay, Prof.
- Phone Number: +33 369 55 03 13
- Email: gerard.gay@chru-strasbourg.fr
-
Contact:
- Michel Delvaux, Prof.
- Phone Number: +33-369 55 03 13
- Email: michel.delvaux@chru-strasbourg.fr
-
Principal Investigator:
- Gerard Gay, MD
-
Sub-Investigator:
- Michel Delvaux, MD
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 80 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Subject is >= 18 and ≤ 80 years old, referred to colonoscopy
- Subject is able and agrees to sign the informed consent and follow the study requirements
Exclusion Criteria:
- Myocardial infarction within the last 3 months
- Symptomatic congestive heart failure
- Established renal failure (serum creatinine > 2.0 mg/dL)
- Previous abdominal surgery, colectomy, or recent colon or rectal surgery
- Abdominal hernia
- Partial or complete intestinal obstruction
- Acute exacerbation of inflammatory bowel disease
- Intestinal perforation
- Fissures or fistula
- Grade III or IV hemorrhoids
- Carcinoma of the rectum
- Distal rectal anastomosis
- Cirrhosis
- Hypokalemia
- Pregnancy
- Subject's weight > 400 lbs. /182 kg
- Participation in another study that may affect the results of this study
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Hydrocolonic cleansing
Subjects undergo colon cleansing by hydrotherapy with the study device
|
The Angel of Water™ system will be used for hydrotherapy of the colon in adult subjects scheduled for elective colonoscopy.
Other Names:
|
|
Active Comparator: Standard preparation solution
Subjects undergo colon cleansing by standard preparation solution
|
The Angel of Water™ system will be used for hydrotherapy of the colon in adult subjects scheduled for elective colonoscopy.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Colon Cleanliness during colonoscopy according to Boston Bowel Preparation Scale (BBPS)
Time Frame: Per patient: the end of procedure; For study: approx. 10 months
|
The primary study outcome is the Boston Bowel Preparation Scale (BBPS) score evaluating during colonoscopy.
The BBPS is a valid scale for measuring bowel preparation as well as colonoscopy outcomes, as it reflects the colon's cleanliness during the inspection phase of the procedure.
|
Per patient: the end of procedure; For study: approx. 10 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Subject's Attitude: rating the preparation procedure with respect to ease, convenience and comfort
Time Frame: Per patient: the end of procedure; For study: approx. 10 months
|
Each subject will be asked to answer post cleansing questionnaire and a score will be calculated.
|
Per patient: the end of procedure; For study: approx. 10 months
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Duration of colonoscopy examination
Time Frame: Per patient: the end of procedure; For study: approx. 10 months
|
The duration of the colonoscopy procedure will be recorded for each subject.
The duration is defined as the time from insertion into the rectum to the time when the colonoscopy is withdrawn across the anus.
|
Per patient: the end of procedure; For study: approx. 10 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Director: Eran Choman, novoGI
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
June 1, 2013
Primary Completion (Anticipated)
March 1, 2014
Study Completion (Anticipated)
March 1, 2014
Study Registration Dates
First Submitted
June 4, 2013
First Submitted That Met QC Criteria
June 4, 2013
First Posted (Estimate)
June 6, 2013
Study Record Updates
Last Update Posted (Estimate)
June 6, 2013
Last Update Submitted That Met QC Criteria
June 4, 2013
Last Verified
June 1, 2013
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Hydro-Prep, CLPR-200-0101
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Colon Diseases
-
NorgineXolomon Tree S.L.CompletedColon Cancer | Colon Disease | Colon CleansingSpain, Portugal
-
PeerMedical Ltd.CompletedColon Cancer | Colon Adenomas | Colon Polyps | Colon DiseasesIsrael
-
Ostfold Hospital TrustCompletedColon Cancer | Benign Colon DiseasesNorway
-
Robert Bosch Gesellschaft für Medizinische Forschung...Ovesco Endoscopy AG; Tuebingen Scientific Medical GmbHRecruitingAdenoma Colon | Adenoma Colon PolypGermany
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)Active, not recruitingStage III Colon Cancer AJCC v8 | Colon Adenocarcinoma | Microsatellite Stable Colon Carcinoma | Stage IIB Colon Cancer AJCC v8 | Stage IIC Colon Cancer AJCC v8United States
-
Gruppo Oncologico del Nord-OvestSeagen Inc.; Servier; Foundation MedicineSuspendedStage II Colon Cancer | Stage III Colon Cancer | HER2-positive Colon Cancer | RAS Wild-type Colon CancerItaly
-
Chang Gung Memorial HospitalCompletedColon Cancer | Cancer Recurrence | Colon Adenocarcinoma | Colon Cancer Stage II | Colon Cancer Stage I | Survival Analysis | Colon Cancer Stage IIITaiwan
-
National Cancer Institute (NCI)NSABP Foundation IncCompletedColon Adenocarcinoma | Stage IIIA Colon Cancer AJCC v7 | Stage IIIB Colon Cancer AJCC v7 | Stage IIIC Colon Cancer AJCC v7 | Stage IIA Colon Cancer AJCC v7 | Stage IIB Colon Cancer AJCC v7 | Stage IIC Colon Cancer AJCC v7United States
-
University Hospitals Cleveland Medical CenterApollo Endosurgery, Inc.CompletedColon Malignant Tumor | Colon Benign TumorUnited States
-
Intuitive SurgicalCompletedBenign Right Colon Disease | Malignant Right Colon DiseaseUnited States
Clinical Trials on Colon cleansing by hydrotherapy
-
Luigi Sacco University HospitalCompleted
-
National Taiwan University HospitalCompleted
-
Universidad Complutense de MadridNot yet recruitingHydrotherapy | Constipation - Functional | Functional Colonic DiseasesSpain
-
NYU Langone HealthWithdrawn
-
University of La LagunaCompleted
-
Seoul National University HospitalSeoul National UniversityCompletedAdenoma | Colonoscopy | Sessile Serrated AdenomaKorea, Republic of